Industry Suggests Increase In Spiked Supplements Reflects FDA Investment In Testing, Targeted Selection
This article was originally published in The Tan Sheet
Executive Summary
The number of products marketed as supplements and identified as tainted in 2013 grew 136% from 2011 – the year after FDA announced it would take “swift and strong” enforcement action. Trends in recalls and public notifications likely reflect FDA’s investment in testing products, a strategy in need of updating, supplement industry trade groups say.
You may also be interested in...
Weight Loss Products Provide Ample Targets In FDA War On Spiked Supplements
FDA finds four weight loss products that contain potentially dangerous undeclared ingredients, including DMAA and sibutramine. The agency also continues to warn about bee pollen with undeclared ingredients.
Weight Loss Products Provide Ample Targets In FDA War On Spiked Supplements
FDA finds four weight loss products that contain potentially dangerous undeclared ingredients, including DMAA and sibutramine. The agency also continues to warn about bee pollen with undeclared ingredients.
In Brief: GSK Sales Drop; FTC Bans Firm From U.S. Market; FDA Warning Letters
GSK consumer sales drop 4%; Canadian firm banned from weight loss market; basic labeling failures triggers FDA warning letter; claims make Puna Noni products drugs; FDA finds another tainted supplement; and study shows Herbalife is not pyramid scheme.